[
    [
        {
            "time": "2023-10-18",
            "original_text": "CRO/CDMO企业中报亮眼，药审中心新规“影响”几何？",
            "features": {
                "keywords": [
                    "CRO",
                    "CDMO",
                    "中报",
                    "药审中心",
                    "新规"
                ],
                "sentiment_score": 0.6,
                "policy_related": "true",
                "investment_strategy": "false",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "false",
                "ts_effect_direction": "neutral"
            },
            "scores": {
                "News_content": "CRO/CDMO企业中报亮眼，药审中心新规“影响”几何？",
                "Correlation": 8,
                "Sentiment": 6,
                "Importance": 7,
                "Impact": 6,
                "Duration": 7,
                "Entity_Density": 5,
                "Market_Scope": 8,
                "Time_Proximity": 7,
                "Headline_Structure": 8,
                "Source_Recency": 7
            }
        },
        {
            "time": "2023-10-18",
            "original_text": "博腾股份等多家CXO企业绩超预期 细胞基因治疗带富CDMO“卖水人”",
            "features": {
                "keywords": [
                    "博腾股份",
                    "CXO",
                    "细胞基因治疗",
                    "CDMO"
                ],
                "sentiment_score": 0.9,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "博腾股份等多家CXO企业绩超预期 细胞基因治疗带富CDMO“卖水人”",
                "Correlation": 9,
                "Sentiment": 8,
                "Importance": 8,
                "Impact": 7,
                "Duration": 7,
                "Entity_Density": 7,
                "Market_Scope": 7,
                "Time_Proximity": 8,
                "Headline_Structure": 8,
                "Source_Recency": 8
            }
        },
        {
            "time": "2023-10-18",
            "original_text": "凯莱英遭高瓴减持，主业增速不敌直接竞对，重仓的新业务也没起量 减持股份",
            "features": {
                "keywords": [
                    "凯莱英",
                    "高瓴",
                    "减持",
                    "新业务"
                ],
                "sentiment_score": -0.7,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "negative",
                "affected_by_time_series": "true",
                "ts_effect_direction": "negative"
            },
            "scores": {
                "News_content": "凯莱英遭高瓴减持，主业增速不敌直接竞对，重仓的新业务也没起量 减持股份",
                "Correlation": 9,
                "Sentiment": 3,
                "Importance": 9,
                "Impact": 8,
                "Duration": 6,
                "Entity_Density": 8,
                "Market_Scope": 5,
                "Time_Proximity": 8,
                "Headline_Structure": 9,
                "Source_Recency": 8
            }
        },
        {
            "time": "2023-10-18",
            "original_text": "智通每日大行研报丨高盛予阅文集团(00772)目标价76港元 汇丰研究指海丰国际(01308)估值吸引",
            "features": {
                "keywords": [
                    "高盛",
                    "阅文集团",
                    "汇丰研究",
                    "海丰国际",
                    "估值"
                ],
                "sentiment_score": 0.5,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "传媒",
                    "航运"
                ],
                "causal_factor": "false",
                "causal_impact": "neutral",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "智通每日大行研报丨高盛予阅文集团(00772)目标价76港元 汇丰研究指海丰国际(01308)估值吸引",
                "Correlation": 6,
                "Sentiment": 7,
                "Importance": 6,
                "Impact": 5,
                "Duration": 5,
                "Entity_Density": 6,
                "Market_Scope": 4,
                "Time_Proximity": 7,
                "Headline_Structure": 7,
                "Source_Recency": 7
            }
        },
        {
            "time": "2023-10-18",
            "original_text": "热门股回调成大跌主因？不要慌，短线或快速企稳",
            "features": {
                "keywords": [
                    "热门股",
                    "回调",
                    "大跌",
                    "企稳"
                ],
                "sentiment_score": -0.4,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "综合"
                ],
                "causal_factor": "true",
                "causal_impact": "negative",
                "affected_by_time_series": "true",
                "ts_effect_direction": "negative"
            },
            "scores": {
                "News_content": "热门股回调成大跌主因？不要慌，短线或快速企稳",
                "Correlation": 5,
                "Sentiment": 6,
                "Importance": 5,
                "Impact": 5,
                "Duration": 4,
                "Entity_Density": 3,
                "Market_Scope": 7,
                "Time_Proximity": 8,
                "Headline_Structure": 8,
                "Source_Recency": 8
            }
        },
        {
            "time": "2023-10-18",
            "original_text": "港股医药板块跌幅扩大 药明康德跌逾8%",
            "features": {
                "keywords": [
                    "港股",
                    "医药板块",
                    "药明康德",
                    "跌幅"
                ],
                "sentiment_score": -0.8,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "false",
                "causal_impact": "neutral",
                "affected_by_time_series": "true",
                "ts_effect_direction": "negative"
            },
            "scores": {
                "News_content": "港股医药板块跌幅扩大 药明康德跌逾8%",
                "Correlation": 9,
                "Sentiment": 3,
                "Importance": 8,
                "Impact": 9,
                "Duration": 6,
                "Entity_Density": 7,
                "Market_Scope": 8,
                "Time_Proximity": 9,
                "Headline_Structure": 7,
                "Source_Recency": 9
            }
        },
        {
            "time": "2023-10-18",
            "original_text": "浦银国际证券维持药明康德买入评级：CDMO业务增长强劲，全球需求仍旺盛",
            "features": {
                "keywords": [
                    "浦银国际证券",
                    "药明康德",
                    "CDMO",
                    "买入评级"
                ],
                "sentiment_score": 0.8,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "浦银国际证券维持药明康德买入评级：CDMO业务增长强劲，全球需求仍旺盛",
                "Correlation": 9,
                "Sentiment": 8,
                "Importance": 7,
                "Impact": 6,
                "Duration": 7,
                "Entity_Density": 8,
                "Market_Scope": 6,
                "Time_Proximity": 7,
                "Headline_Structure": 7,
                "Source_Recency": 7
            }
        },
        {
            "time": "2023-10-18",
            "original_text": "里昂：维持药明康德(02359)“买入”评级 目标价升21.8%至212.9港元",
            "features": {
                "keywords": [
                    "里昂",
                    "药明康德",
                    "买入评级",
                    "目标价"
                ],
                "sentiment_score": 0.7,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "false",
                "causal_impact": "neutral",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "里昂：维持药明康德(02359)“买入”评级 目标价升21.8%至212.9港元",
                "Correlation": 9,
                "Sentiment": 9,
                "Importance": 8,
                "Impact": 7,
                "Duration": 7,
                "Entity_Density": 8,
                "Market_Scope": 6,
                "Time_Proximity": 8,
                "Headline_Structure": 8,
                "Source_Recency": 8
            }
        },
        {
            "time": "2023-10-18",
            "original_text": "11倍牛股跌停！高瓴砍仓50%，最牛赛道不香了？",
            "features": {
                "keywords": [
                    "牛股",
                    "跌停",
                    "高瓴",
                    "砍仓",
                    "赛道"
                ],
                "sentiment_score": -0.9,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "negative",
                "affected_by_time_series": "true",
                "ts_effect_direction": "negative"
            },
            "scores": {
                "News_content": "11倍牛股跌停！高瓴砍仓50%，最牛赛道不香了？",
                "Correlation": 8,
                "Sentiment": 3,
                "Importance": 9,
                "Impact": 9,
                "Duration": 6,
                "Entity_Density": 6,
                "Market_Scope": 8,
                "Time_Proximity": 9,
                "Headline_Structure": 10,
                "Source_Recency": 9
            }
        }
    ]
]